Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (IN201817032726) TLR7 AGONIST TRIFLUOROACETATE SALT AND CRYSTALLINE FORM B THEREOF PREPARATION METHODS AND USES

Office : India
Application Number: 201817032726 Application Date: 31.08.2018
Publication Number: 201817032726 Publication Date: 01.02.2019
Publication Kind : A
Prior PCT appl.: Application Number:PCTCN2017072894 ; Publication Number:PCTCN2017072894 Click to see the data
IPC:
C07D 487/04A
[IPC code unknown for ERROR IPC Code incorrect: invalid subgroup (0=>999999)!]
Applicants: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
Inventors: DING, Zhaozhong
SUN, Fei
HU, Yinghu
ZHOU, Yilong
WANG, Zheng
ZHAO, Rui
YANG, Ling
Priority Data: 201610081899.3 05.02.2016 CN
Title: (EN) TLR7 AGONIST TRIFLUOROACETATE SALT AND CRYSTALLINE FORM B THEREOF PREPARATION METHODS AND USES
Abstract:
(EN) The present invention relates to a trifluoroacetate salt of a TLR7 agonist 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[32-d]pyrimidin-4-amine (formula I) crystalline form B of the trifluoroacetate salt methods for preparing the trifluoroacetate salt and crystalline form B and uses of the trifluoroacetate salt and crystalline form B.
Also published as:
UAa201809128AU2017214135CA3013521MYPI 2018702700SG11201806688QKR1020180104118
CN108602833EP3412674IL260981BR112018015878US20190031666EA201891772
ID2018/12857PH1/2018/501641WO/2017/133687